day 1 agenda
| 9th International Webinar on COGNITIVE AND BEHAVIORAL NEUROSCIENCES March 18, 2024 (GMT - London Time) |
|
| Meeting ID: 865 0883 2755 Passcode: 898216 |
|
| 10:10-10:30 | Nutritional Approaches in Comperensive Clinical Trials Targeting Biological and Cognitive Function in Alzheimer Disease |
| OZNUR OZGE OZCAN, Uskudar University, Turkey | |
| 10:30-10:50 | Evolution of Reasons for Living and Dying among Individuals with a History of Suicide Attempts: A Two-Year Follow-Up Investigation |
| Anja C. Gysin-Maillart, Translational Research Center, Switzerland | |
| 10:50-11:20 | Design, Synthesis, Metal Chelation Potential and Biological Evaluation of Pyridine Chalcones as Multi-Target-Directed Ligands against Alzheimer’s Disease |
| Arati Prabhu, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, India | |
| 11:20-11:50 | The perceptions of different professionals on school absenteeism and the role of school health care: a focus group study conducted in Finland |
| Katja Melander,University of Helsinki, Finland | |
| 11:50-12:10 | The function of human Oxidation Resistance 1 (OXR1) in neurodevelopmental disorders |
| Jing Ye, Norwegian University of Science and Technology (NTNU), Norway | |
| 12:10-12:30 | The effect of age on the hearing-related quality of life in normal-hearing adults |
| Katrien Kestens, Ghent University, Belgium | |
| 12:30-13:00 | The cognitive map of dancing bees |
| Randolf Menzel, Freie Universitat Berlin, Germany | |
| 13:00-13:20 | Type 2 Diabetes as a risk factor for Alzheimer’s Disease: Perspective from a Drosophila model of Tauopathy and neuroblastoma cells |
| Shreyasi Chatterjee, Nottingham Trent University, UK | |
| 13:20-13:40 | Is there a relationship between Alzheimer’s and Periodontal disease? Comparative analysis |
| Daniela Torrealba-Garcia, Spain | |
| 13:40-14:00 | Repurposing of gene expression data for brain research – is it possible? |
| Angelica Lindlof, University of Skovde, sweden | |
| 14:00-14:20 | Chronic impact of cannabis to the brain GABA and glutamate system: from regions to pathway |
| Stephanie M Hare, University of Maryland School of Medicine, USA | |
| 14:20-14:40 | An updated assessment of FPR2 receptor modulation on microglia cells isolated from adult APPNL-F/NL-F mice: the new direction in LPS-stimulated conditions |
| Jakub Kosma Frydrych, Maj Institute of Pharmacology PAS, Poland | |
| 14:40-15:00 | Substance use treatment for American Indian and Alaska Native populations: Qualitative study of barriers and opportunities by an implementation framework |
| Claradina Soto, University of Southern California, USA | |
| 15:00-15:20 | Relation between white matter integrity, perfusion, and processing speed in early-stage schizophrenia |
| Andreia V Faria, JHU, USA | |
| 15:20-15:40 | Neurotrophic Factor- α1 Gene Therapy Prevents Memory Loss and Alzheimer’s Disease pathology in 3xTg-AD mice |
| Y. Peng Loh, National Institutes of Health, USA | |
| 15:40-16:00 | Hsp90 co-chaperons regulate neurodegenerative disease-associated proteins |
| Umesh Jinwal, University of South Florida, USA | |
| 16:00-16:30 | Epigenetic modifiers as game changers for healthy aging |
| Shikha Sharma, Instem, Bangalore, India | |
| 16:30-16:50 | Oral medicine a viable target in dementia prevention |
| Anne O. Rice, Wichita State University, USA | |
| 16:50-17:10 | Is it possible to prevent Alzheimer disease by inserting of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 Base editing and Prime editing technologies? |
| Jacques P. Tremblay, Laval university, Canada | |
| 17:10-17:30 | Structural Mapping of Protein Aggregates in Live Eukaryotic Cells |
| Giulio Chiesa, University of Toronto, Canada | |
| 17:30-17:50 | Unveiling the Genomic Landscape of Alzheimer's Disease and Progressive Supranuclear Palsy Through Large-Scale Whole Genome Sequencing Data |
| Wan-Ping Lee, University of Pennsylvania, USA | |
| closing remarks | |